The Dihydrouracil/Uracil Ratios in Plasma and Toxicities of 5-Fluorouracil-Based Adjuvant Chemotherapy in Colorectal Cancer Patients

Publisher： Karger

E-ISSN： 1421-9794|53|2|127-131

ISSN： 0009-3157

Source： Chemotherapy, Vol.53, Iss.2, 2007-02, pp. : 127-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recurrent Thrombophlebitis in a Colon Cancer Patient with C677T Heterozygous Genotype for MTHFR Treated with 5-Fluorouracil-Based Adjuvant Chemotherapy

By  

Chemotherapy, Vol. 50, Iss. 4, 2004-10 ,pp. : 194-195

Karger

Access to resources Recommend Favorite

5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Advanced Pancreatic Cancer Who Have Progressed on Gemcitabine-Based Therapy

By  

Chemotherapy, Vol. 59, Iss. 4, 2014-01 ,pp. : 273-279

Karger

Access to resources Recommend Favorite

Efficacy of Gemcitabine for Locally Advanced Pancreatic Cancer: Comparison with 5-Fluorouracil-Based Chemoradiotherapy

By  

Chemotherapy, Vol. 54, Iss. 4, 2008-08 ,pp. : 302-308

Karger

Access to resources Recommend Favorite

The Role of Pharmacogenetics and Pharmacogenomics in Cancer Chemotherapy with 5-Fluorouracil

By  

Pharmacology, Vol. 61, Iss. 3, 2000-09 ,pp. : 199-203

Karger

Access to resources Recommend Favorite

Upregulation of Enzymes Metabolizing 5-Fluorouracil in Colorectal Cancer

By  

Chemotherapy, Vol. 53, Iss. 1, 2006-12 ,pp. : 36-41

Karger

Access to resources Recommend Favorite